Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19. (2021)

First Author: Gaziano L
Attributed to:  Aetiology of type 2 diabetes and related metabolic disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-021-01310-z

PubMed Identifier: 33837377

Publication URI: http://europepmc.org/abstract/MED/33837377

Type: Journal Article/Review

Volume: 27

Parent Publication: Nature medicine

Issue: 4

ISSN: 1078-8956